March 13, 2019 – Translational Stroke Research, Syed M. Adil, Beiyu Liu, et al Abstract – Hydrocephalus is one of…
Minnetronix Neuro Launches Global Neurapheresis™ Research Consortium
Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system
Minnetronix Neuro Successfully Completes First Clinical Study in Hemorrhagic Stroke
Minnesota-based Company to Present at Late Breaking Session during Congress of Neurological Surgeons
Contract med-tech manufacturer Minnetronix to launch own device
Minnetronix is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke.
Feasibility of Neurapheresis™ Therapy for Multidrug Resistant Gram-negative Bacterial Meningitis
October 4, 2017 – Duke University Medical Center/Minnetronix Neuro Pseudomonas, Acinetobacter and Klebsiella are three multidrug resistant (MDR) gram-negative pathogens…